Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated…
- Researchers will utilize Iktos generative modeling AI technology with SRIs SynFini synthetic chemistry platform to discover new compounds against multiple viruses, including the Wuhan coronavirus (COVID-19) -
Iktos, a company specialized in artificial intelligence (AI) for novel drug design and SRI International (SRI), a research center headquartered in Menlo Park, California, today announced that the companies have entered into a collaboration agreement designed to accelerate discovery and development of novel anti-viral therapies. Under the collaboration, Iktos generative modeling technology will be combined with SRIs SynFini, a fully automated end-to-end synthetic chemistry system, to design novel, optimized compounds and accelerate the identification of drug candidates to treat multiple viruses, including influenza and the Wuhan coronavirus (COVID-19).
Iktos AI technology, based on deep generative models, helps bring speed and efficiency to the drug discovery process by automatically designing virtual novel molecules that have all of the desirable characteristics of a novel drug candidate. This tackles one of the key challenges in drug design: rapid and iterative identification of molecules which simultaneously validate multiple bioactive attributes and drug-like criteria for clinical testing.
"Iktos generative AI technology has proven its value and potential to accelerate drug discovery programs in multiple collaborations with renowned pharmaceutical companies. We are eager to apply it to SRIs endonuclease program, and hope our collaboration with SRI can make a difference and speed up the identification of promising new therapeutic option for the treatment of COVID-19," said Yann Gaston-Math, co-founder and CEO of Iktos. "We are excited at the prospect of combining our automated compound design technology with SRIs SynFini platform and the potential this has to further accelerate drug discovery."
SRIs SynFini platform is designed to accelerate chemical discovery and development, and thereby bring new drugs to the clinic more quickly and affordably. The closed loop SynFini platform automates the design, reaction screening and optimization (RSO), and production of target molecules. SynFini comprises three components that work seamlessly together: a software platform (SynRoute), a reaction screening platform (SynJet), and a multi-step flow chemistry automation and development platform (AutoSyn).
SRI has an ongoing program focused on discovering drugs to block endonuclease enzymes that are common to many viruses. These enzymes are involved in viral replication and blocking of host resistance to infection. Sequence analysis of COVID-19 indicates that this virus has an endonuclease that it is genetically about 97 percent similar to the SARS virus. Recent studies show that blocking the SARS virus endonuclease inhibits the infections pathogenesis, leading to a 100 percent survival rate in preclinical models. This suggests that the COVID-19 endonuclease is a good therapeutic target.
"The SynFini system has the potential to dramatically expedite small molecule drug discovery," said Nathan Collins, Ph.D., Chief Strategy Officer of SRIs Biosciences Division and Head of the SynFini program. "We look forward to exploring how the integration of Iktos AI-driven generative molecule combined with SynFini supports the rapid and efficient discovery of new drugs to treat emerging infectious diseases."
By combining platforms for the accelerated molecular design and automated production of target molecules with established high-throughput biology, Iktos and SRI hope to demonstrate a new paradigm in extremely rapid drug discovery against high-value pharmaceutical targets.
About Iktos
Incorporated in October 2016, Iktos is a French start-up company specialized in the development of artificial intelligence solutions applied to chemical research, more specifically medicinal chemistry and new drug design. Iktos is developing a proprietary and innovative solution based on deep learning generative models, which enables, using existing data, to design molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology both as professional services and as a SaaS software platform, Makya. Iktos is also developing Spaya, a synthesis planning software based upon Iktoss proprietary AI technology for retrosynthesis.
Story continues
About SRI International
SRI International, a non-profit research institute founded in 1946 and headquartered in Menlo Park, California, creates world-changing solutions to make people safer, healthier, and more productive. SRI Biosciences, a division of SRI International, integrates basic biomedical research with drug and diagnostics discovery, and preclinical and clinical development. SRI Biosciences has produced several marketed drugs and advanced more than 100 drugs to clinical trials. The division is focused on novel platforms and programs in a variety of therapeutic areas targeting high unmet medical needs. SRI Biosciences collaborates with a broad range of partners from small and virtual biotechnology companies to top 10 pharmaceutical companies and other leading industry partners. More information is available at http://www.sri.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200303005770/en/
Contacts
For Iktos Yann Gaston-Math, CEOcontact@iktos.com +33 6 30 07 99 26
For SRI Melissa Wagner, Business Developmentmelissa.wagner@sri.com +1 650 859 3505
Michele Parisi, Mediamparisi@forwardhealthinc.com +1 925 864 5028
View original post here:
Iktos and SRI International Announce Collaboration to Combine Artificial Intelligence and Novel Automated Discovery Platform for Accelerated...
- Senate bill targets the use of artificial intelligence in Mississippi - WAPT Jackson - March 15th, 2025 [March 15th, 2025]
- will.i.am and Sean Paul on embracing artificial intelligence in music - Sky News - March 15th, 2025 [March 15th, 2025]
- As Artificial Intelligence (AI) Stocks Fall, Investors Should Consider Buying More of These 2 Powerhouses - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- FSUs Graduate School hosts workshop on artificial intelligence to explore the impact of AI on teaching and research - Florida State News - March 15th, 2025 [March 15th, 2025]
- Artificial Intelligence Optimization (AIO): The Next Frontier in SEO - hackernoon.com - March 15th, 2025 [March 15th, 2025]
- The U.S. Army, Artificial Intelligence, and Mission Command - War On The Rocks - March 15th, 2025 [March 15th, 2025]
- 2 Stock-Split Artificial Intelligence (AI) Stocks to Buy Before They Zoom Higher, According to Wall Street Analysts - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- AI in the classroom: How artificial intelligence is helping teachers - Bay News 9 - March 15th, 2025 [March 15th, 2025]
- Video: Daryl Morey Says 76ers Use Artificial Intelligence for Input on Team Decisions - Bleacher Report - March 15th, 2025 [March 15th, 2025]
- Better Artificial Intelligence Stock: AT&T vs. Verizon Communications - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- NVIDIA GTC 25: What To Expect From the Years Biggest Artificial Intelligence Event - BizTech Magazine - March 15th, 2025 [March 15th, 2025]
- 2 Stock-Split Artificial Intelligence (AI) Stocks to Buy Before They Zoom Higher, According to Wall Street Analysts - MSN - March 15th, 2025 [March 15th, 2025]
- DEI Erosion Threatens Safety. Artificial Intelligence May Help Pick Up the Slack. - Inbound Logistics - March 15th, 2025 [March 15th, 2025]
- Saint Vincent conference will examine broad impact of artificial intelligence - TribLIVE - March 15th, 2025 [March 15th, 2025]
- As Artificial Intelligence (AI) Stocks Fall, Investors Should Consider Buying More of These 2 Powerhouses - MSN - March 15th, 2025 [March 15th, 2025]
- 3 Artificial Intelligence (AI) Stocks You Can Buy and Hold for the Next Decade - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- This Artificial Intelligence (AI) Stock Has Surged 1,000% Over the Past 2 Years. Is a Split on the Horizon? - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Move Over, Artificial Intelligence (AI) -- Businesses Are on Pace to Spend More Than $10 Trillion on This Trend Over the Next Decade - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Here Is My Top Artificial Intelligence (AI) Stock to Buy Right Now - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Nasdaq Sell-Off: 2 Artificial Intelligence (AI) Stocks Down 20% and 49% to Buy Hand Over Fist on the Dip - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 1 Top Artificial Intelligence (AI) Chip Stock to Buy Hand Over Fist Before It Jumps - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- [Latest] How Artificial Intelligence is Shaping the Emc Shielding And Test Equipment Market - openPR - March 15th, 2025 [March 15th, 2025]
- Nasdaq Correction: 5 Reasons Nvidia Stock Is Still a Top Artificial Intelligence (AI) Stock to Buy Right Now - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Artificial Intelligence (AI) Adoption Rates Appear Low, but This Technology Leader Could See a Massive Surge in Demand in the Next 10 Years. Here's... - March 15th, 2025 [March 15th, 2025]
- [Latest] The Influence of Artificial Intelligence on the Augmented Reality (Ar) Shopping Market - openPR - March 15th, 2025 [March 15th, 2025]
- Oracle Just Shared Some Amazing News for the Entire Artificial Intelligence (AI) Industry - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 1 No-Brainer Artificial Intelligence (AI) ETF to Buy With $40 During the Nasdaq Sell-Off - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Inside The Artificial Intelligence That Can Clone Your Mind - Forbes - March 15th, 2025 [March 15th, 2025]
- Why Tesla Could Be a Massive Winner in the Artificial Intelligence (AI) Race - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- 4 Artificial Intelligence (AI) Stocks Worth Buying in the Tech Sell-Off - The Motley Fool - March 15th, 2025 [March 15th, 2025]
- Impact of Artificial Intelligence (AI) on Media and Creative Industries - EDMO - March 1st, 2025 [March 1st, 2025]
- 1 Artificial Intelligence (AI) Stock That Could Be Bigger Than Nvidia in 5 Years - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Can artificial intelligence be the future solution to the enormous challenges and suffering caused by Schizophrenia? - Nature.com - March 1st, 2025 [March 1st, 2025]
- Applications of Artificial Intelligence in Medical Education: A Systematic Review - Cureus - March 1st, 2025 [March 1st, 2025]
- This Artificial Intelligence (AI) Stock Is Up 15% in 2025 Already. It Is Still a Solid Buy? - AOL - March 1st, 2025 [March 1st, 2025]
- Federal Executive Forum Artificial Intelligence Strategies in Government Progress and Best Practices 2025 - Federal News Network - March 1st, 2025 [March 1st, 2025]
- Introduction to Artificial Intelligence for General Surgeons: A Narrative Review - Cureus - March 1st, 2025 [March 1st, 2025]
- How is Artificial Intelligence Affecting Health Care? - Workers Comp Forum - March 1st, 2025 [March 1st, 2025]
- 1 Spectacular Artificial Intelligence (AI) Stock to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 20+ Advantages and Disadvantages of AI | Pros of Artificial Intelligence - Simplilearn - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 1 Surprising Stock Harnessing the Power of Artificial Intelligence (AI) - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks to Buy On the Dip Amid Nasdaq Selloff - Yahoo Finance - March 1st, 2025 [March 1st, 2025]
- Review: Artificial intelligence is shaping the future of diabetes care - News-Medical.Net - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Stock -- a 1,020% Gainer Since Its IPO -- Won't Split Its Stock in 2025. Here's Why - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- A Nobel laureate on the economics of artificial intelligence - MIT Technology Review - March 1st, 2025 [March 1st, 2025]
- Prediction: This Top Artificial Intelligence (AI) Stock Will Start Skyrocketing After March 6 - Nasdaq - March 1st, 2025 [March 1st, 2025]
- Meta Platforms Just Caused This Crucial Artificial Intelligence (AI) Stock to Plummet. Should You Buy the Dip? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Artificial Intelligence - AI Update, February 28, 2025: AI News and Views From the Past Week - MarketingProfs.com - March 1st, 2025 [March 1st, 2025]
- The Ultimate Artificial Intelligence (AI) ETF to Buy With $50 Right Now - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Prediction: This Artificial Intelligence (AI) Company Will Split Its Stock in 2025 - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Should You Forget Nvidia and Buy 2 Artificial Intelligence (AI) Stocks Instead? - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- Why Artificial Intelligence Stocks SoundHound AI, IonQ, and C3.ai Are Struggling Today - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- 2 Top Artificial Intelligence (AI) Stocks Ready for a Bull Run - The Motley Fool - March 1st, 2025 [March 1st, 2025]
- AI Cant Do This Anymore: The Dangers of Artificial Intelligence in Academia - Skidmore News - March 1st, 2025 [March 1st, 2025]
- Whats Next in Artificial Intelligence: Agents that can do more than chatbots - Pittsburgh Post-Gazette - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Yahoo - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Associated Press - February 9th, 2025 [February 9th, 2025]
- 3 Top Artificial Intelligence Stocks to Buy in February - MSN - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - Lufkin Daily News - February 9th, 2025 [February 9th, 2025]
- 2 of the Hottest Artificial Intelligence (AI) Stocks on the Planet Can Plunge Up to 94%, According to Select Wall Street Analysts - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- These 2 Stocks Are Leading the Data Center Artificial Intelligence (AI) Trend, but Are They Buys Right Now? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Book Review | Genesis: Artificial Intelligence, Hope, and the Human Spirit - LSE - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence Action Summit In France: Maintaining The Dialogue On Global AI Regulation - Forrester - February 9th, 2025 [February 9th, 2025]
- Is prediction the next frontier for artificial intelligence? - Healthcare IT News - February 9th, 2025 [February 9th, 2025]
- The Artificial Intelligence in Medicines Market Is Set to Reach $18,119 Million | CAGR of 49.6% - openPR - February 9th, 2025 [February 9th, 2025]
- Geopolitics of artificial intelligence to be focus of major summit in Paris; AP explains - The Audubon County Advocate Journal - February 9th, 2025 [February 9th, 2025]
- Around and About with Richard McCarthy: Asking AI about itself: Will artificial intelligence ever surpass humankind? - GazetteNET - February 9th, 2025 [February 9th, 2025]
- Will the Paris artificial intelligence summit set a unified approach to AI governanceor just be another conference? - Bulletin of the Atomic... - February 9th, 2025 [February 9th, 2025]
- Apple Stock Jumps on Artificial Intelligence (AI) Driving iPhone Sales. Here's Why It's Not Getting Crushed by the DeepSeek Launch. - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Who will win the race to Artificial General Intelligence? - The Indian Express - February 9th, 2025 [February 9th, 2025]
- Prediction: This Artificial Intelligence (AI) Chip Stock Will Win Big From DeepSeek's Feat - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Prediction: 2 Artificial Intelligence (AI) Stocks That Will Be Worth More Than Nvidia 3 Years From Now - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- State of Louisiana Launches Innovation Brand, Announces Creation of $50 Million Growth Fund and Artificial Intelligence Research Institute - Louisiana... - February 9th, 2025 [February 9th, 2025]
- Using smart technologies and artificial intelligence in food packaging can reduce food waste - Yahoo News Canada - February 9th, 2025 [February 9th, 2025]
- BigBear.ai Wins Department of Defense Contract to Prototype Near-Peer Adversary Geopolitical Risk Analysis for Chief Digital and Artificial... - February 9th, 2025 [February 9th, 2025]
- Should Investors Change Their Artificial Intelligence (AI) Investment Strategy After the DeepSeek Launch? - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- 1 Unstoppable Artificial Intelligence (AI) Stock to Buy Before It Punches Its Ticket to the $4 Trillion Club - The Motley Fool - February 9th, 2025 [February 9th, 2025]
- Got 10 Years and $1000? These 3 Artificial Intelligence (AI) Stocks Are Set to Soar. - The Motley Fool - February 9th, 2025 [February 9th, 2025]